Seeking Alpha

The Burrill Report » Articles » CGRB |

More on CGRB by The Burrill Report

Latest Comments on The Burrill Report's Articles

  1. jay brebner on This Week's Biotech Deal-Making and Financing: Aveo is definitely the company to own for the long haul as well as... more »
  2. Factation on This Week's Failed Trials, Missed Targets in Biotech : Relating to, "A gel designed to prevent AIDS infections produced... more »
  3. johnnysize on Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake : Thanks Monkeys... I now own a cheap takeout stock with huge growth... more »
  4. Alessandro on BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions: I saw a television special espousing the benefits of biochar and... more »
  5. Alessandro on BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions: On Dec 13 07:47 PM auto44 wrote: > You are supposed to sell BS... more »
  6. BioGuy on Biotech's Latest Failed Trials, Missed Targets : I think ZymoGenetics was smart to change it's focus to creating... more »
  7. Erich J Knight on BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions: All political persuasions agree, building soil carbon is GOOD. To... more »
  8. auto44 on BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions: You are supposed to sell BS not buy it. On Dec 13 10:13 AM... more »
  9. johnnysize on Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake : oh gee...thats option expiration ...wow. maybe now proration... more »
  10. uncle mike on Life Sciences Co. Execs Enjoying Pay Hikes in the Downturn: bios are always iffee but if you pick them right buy in and out... more »
  11. valuestocksonly on BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions: BFRE is going to play a large role in this nations energy... more »
  12. Walt17 on Eli Lilly Plans Innovation Strategy to Counter Generics Threat: Lilly acknowledges the generic competition. Why does this surprise... more »
  13. User 468179 on Eli Lilly Plans Innovation Strategy to Counter Generics Threat: Eli Lilly sells a drug (Zyprexa) that can cause... more »
  14. johnnysize on Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake : Ahhhh...I get it. When the ratio is set and the S4 is effective we... more »
  15. johnnysize on Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake : Is MJN going into the SPX 500? more »